Abstract
Administration of immunotherapy is rewarding but challenging. The reward is observing how a patient exhibits progressive symptom improvement while at the same time requiring less medication, even to the point of not requiring medications any more. The problem is the specter of a reaction to the immunotherapy injections. Even though the frequency of reactions to testing or immunotherapy administration is low, if a severe reaction were to develop it could have devastating consequences. The patient most at risk for this type of reaction is the asthmatic patient.
The purpose of this article is to bring awareness, both to patients and practitioners, that there are patients with allergy symptoms that are not considered to be allergic because their tests are negative; that there is a large group of patients that have evidence of inflammation of the lower airway but that usually are not identified as asthmatics. Their management should include the same precautions taken to manage the asthmatic patients. Lastly, perceptions of the significance of immunotherapy for the management of the allergic patient, mainly the asthmatic one, will be presented and a discussion about the management of such patient will follow.
Where are your Clinical Trials?
It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized.Â
0 Comments